Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000354100

Medchemexpress LLC 4E1RCat | 328998-25-0 | 99.0% | C28H18N2O6 | 100 MG
SDP

Catalog No. 5000354100
Encompass_Preferred

4E1RCat is an inhibitor of cap-dependent translation, inhibiting the eIF4E:eIF4GI interaction with an IC50 of approximately 4 μM. It interferes with eIF4G and 4E-BP binding, blocking capped mRNA translation activated by CDK1/CYCB1. This compound is for research use only and affects chemosensitivity and targets translation in mice models.

  • Inhibits cap-dependent translation
  • Interferes with eIF4E:eIF4GI interaction
  • Blocks capped mRNA translation
  • Affects chemosensitivity in specific tumor types in mice
  • Sensitizes lymphomas to doxorubicin
  • Targets translation in mice

Catalog No. 50-003-54100 Supplier Medchemexpress LLC Supplier No. HY14427100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

4E1RCat is an inhibitor of cap-dependent translation, inhibiting the eIF4E:eIF4GI interaction with an IC50 of approximately 4 μM. It interferes with eIF4G and 4E-BP binding, blocking capped mRNA translation activated by CDK1/CYCB1. This compound is for research use only and affects chemosensitivity and targets translation in mice models.

  • Inhibits cap-dependent translation
  • Interferes with eIF4E:eIF4GI interaction
  • Blocks capped mRNA translation
  • Affects chemosensitivity in specific tumor types in mice
  • Sensitizes lymphomas to doxorubicin
  • Targets translation in mice

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.